1401 Metronomic topotecan causes a favorable type of therapy-inducedsenescence and prolongs survival in MYCN amplified neuroblastoma xenografts. (September 2015) - Taschner-Mandl, S.; Schwarz, M.; Blaha, J.; Kauer, M.; Kromp, F.; Frank, N.; Rifatbegovic, F.; Weiss, T.; Ladenstein, R.; Hohenegger, M.; Ambros, I.; Ambros, P.